OVARIAN CARCINOMA Immune Therapy. Antibodies to CA-125 (Ovarex) Vaccine therapy

Similar documents
General history. Basic Data : Age :62y/o Date of admitted: Married status : Married

GENERAL DATA. Sex : female Age : 40 years old Marriage status : married

CA125 in the diagnosis of ovarian cancer: the art in medicine

Triage of Ovarian Masses. Andreas Obermair Brisbane

Gynecologic Oncologist. Surgery Chemotherapy Radiation Therapy Hormonal Therapy Immunotherapy. Cervical cancer

Staging and Treatment Update for Gynecologic Malignancies

New Cancer Cases By Site Breast 28% Lung 14% Colo-Rectal 10% Uterus 6% Thyroid 5% Lymphoma 4% Ovary 3%

Sarah Burton. Lead Gynae Oncology Nurse Specialist Cancer Care Cymru

MPH Quiz. 1. How many primaries are present based on this pathology report? 2. What rule is this based on?

Winship Cancer Institute of Emory University Optimizing First Line Treatment of Advanced Ovarian Cancer

Endometrial Cancer. Incidence. Types 3/25/2019

Practice of Medicine-1 Ovarian Cancer Clinical Correlation

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

Work up of a Pelvic Mass

Case Scenario 1. 1/2/13 History: 64-year-old white female presented with right leg swelling and redness, abdominal pain.

See the latest estimates for new cases of ovarian cancer and deaths in the US and what research is currently being done.

NAACCR Webinar Series 1 Q&A. Fabulous Prizes. Collecting Cancer Data: Ovary 11/3/2011. Collecting Cancer Data: Ovary

Gynecologic Cancer Surveillance and Survivorship: Informing Practice and Policy

IOTA and Models for Screening for Ovarian Cancer

L/O/G/O. Ovarian Tumor. Xiaoyu Niu Obstetrics and Gynecology Department Sichuan University West China Second Hospital

Gynaecological Oncology Cases

receive adjuvant chemotherapy

CASE STUDY. Presented by: Jessica Pizzo. CFCC Sonography student Class of 2018

ACCME/Disclosures. Risk of Gyne Ca in HBOC. Molecular basis of HBOC. Hereditary Ovarian and Breast Cancer Syndrome

Gynecologic Cancers are many diseases. Gynecologic Cancers in the Age of Precision Medicine Advances in Internal Medicine. Speaker Disclosure:

Gynecologic Cancers are many diseases. Speaker Disclosure: Gynecologic Cancer Care in the Age of Precision Medicine. Controversies in Women s Health

GYNECOLOGIC MALIGNANCIES: Ovarian Cancer

Female Genital Tract Lab. Dr. Nisreen Abu Shahin Assistant Professor of Pathology University of Jordan

Ovarian Cancer What you need to know

Approach to imaging of the ovaries

CAN TV U/S REDUCE THE

Ovarian Cancer Includes Epithelial, Fallopian Tube, Primary Peritoneal Cancer, and Ovarian Germ Cell Tumors

Partners: Introductions: Dr. Carolyn Johnston Deanna Cosens & Ann Garvin. Ovarian Cancer and Primary Care July 16, :00 9:00am EST 7/16/2014

PRINCESS MARGARET CANCER CENTRE CLINICAL PRACTICE GUIDELINES GYNECOLOGIC CANCER CERVIX

3 cell types in the normal ovary

[EPUB] RARE LOW GRADE OVARIAN CANCER

Unexpected Gynecologic Findings at Laparotomy. Susan A. Davidson, MD University of Colorado, Denver School of Medicine

Adnexal Masses in Menopausal Women

Please complete prior to the webinar. HOSPITAL REGISTRY WEBINAR FEMALE REPRODUCTIVE SYSTEM EXERCISES CASE 1: FEMALE REPRODUCTIVE

EDUCATIONAL COMMENTARY CA 125. Learning Outcomes

LAPAROSCOPY and OVARIAN CANCER

3/25/2019. Rare uterine cancers ~3% Leiomyosarcoma Carcinosarcoma (MMMT) Endometrial Stromal Sarcomas Aggressive tumors High Mortality Rates

Stage 3 ovarian cancer survival rate

Primary Fallopian Tube Cancer : A Rare Gynecological Malignancy

Clinical guideline Published: 27 April 2011 nice.org.uk/guidance/cg122

Gynaecological cancers. Mr Vivek Nama MD MRCOG Consultant Gynaecological Oncologist

Epithelial Ovarian Cancer

Q: In order to use the code 8461/3 (serous surface papillary) for ovary, does it have to say the term "surface" on the path report?

Stage 3 ovarian cancer survival rate

UTERINE SARCOMA EXAMPLE OF A UTERINE SARCOMA USING PROPOSED TEMPLATE

Histopathological analysis of neoplastic and non neoplastic lesions of ovary: A study of one hundred cases

Assessment of adnexal masses. Ultrasound workup of adnexal masses. symptoms. symptoms. Age. Serum tumor markers 10/1/2018

Cervical cancer presentation

Adnexal Masses in Menopausal Women Surgery or Surveillance?

Case Scenario 1. Pathology report Specimen from mediastinoscopy Final Diagnosis : Metastatic small cell carcinoma with residual lymphatic tissue

Focus on... Ovarian cancer. HE4 & ROMA score

Minimally Invasive Gynecologic Surgery: Laparoscopic Treatment of the Pelvic Mass

Is It Time To Implement Ovarian Cancer Screening?

Interactive Staging Bee

Case 1. Gynaecology Case Presentation. Objectives. Disclosures 22/10/ year old female Clinical history: Assess right ovarian cyst

Ovarian Clear Cell Carcinoma

Pre-operative Evaluation and Implications

Epithelial Ovarian Cancer 8/2/2013. Tu-be or Not Tu-be: Is the Fallopian Tube the Source of Ovarian Cancer?

Chapter 2: Initial treatment for endometrial cancer (including histologic variant type)

IN THE NAME OF GOD POV: CYSTIC OVARIAN LESION

3/25/ % arise from coelomic epithelium

Endometrial cancer. Szabolcs Máté MD. I. St. Department of Obstetrics and Gyneacology.

Joseph Misdraji, M.D. GI pathology Unit Massachusetts General Hospital

Newton Wellesley Hospital 2013

Ovarian, Peritoneal, and Fallopian Tube Epithelial Cancer (OPT)

objectives Pitfalls and Pearls in PET/CT imaging Kevin Robinson, DO Assistant Professor Department of Radiology Michigan State University

A Practical Approach to Adnexal Masses

Ovarian Lesion Benign vs Malignant?

Cpt code for removal of pelvic mass

From Research to Practice: What s New in Gynecologic Cancers?

3 Summary of clinical applications and limitations of measurements

Carcinoma of the Fallopian Tube

Cervical Cancer 3/25/2019. Abnormal vaginal bleeding

6 Week Course Agenda. Today s Agenda. Ovarian Cancer: Risk Factors. Winning the War 11/30/2016 on Women s Cancer Gynecologic Cancer Prevention

Afternoon Session Cases

Borderline Ovarian Tumours. Andreas Obermair Brisbane

Institute of Pathology First Faculty of Medicine Charles University. Ovary

Characterizing Adnexal Masses: Pearls and Pitfalls 20 th Annual Summer Practicum SCBT-MR Jackson Hole August 11, 2010

ARRO Case: Early-stage Endometrial Cancer

Diagnostic accuracy of ultrasonography with color doppler imaging techniques in adnexal masses and correlation with histopathological analysis

The many faces of Endometriosis

4:00 into mp3 file Huang_342831_5_v1.mp3

Guidelines for Assigning Summary Stage 2000

What is endometrial cancer?

Ovarian cancer. Quick reference guide. Issue date: April The recognition and initial management of ovarian cancer

Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study

Pre-operative assessment of patients for cytoreduction and HIPEC

Guideline for the Assessment, Management and Referral of Patients with Suspected Ovarian Cancer

The Adnexal Mass. Handout NCUS 3/18/2017 Suzanne Dixon, MD

Quiz The main functions of the ovaries are a. To produce oocytes b. To produce estrogen c. To produce progesterone d.

Epithelial Ovarian Cancer: Prevention, Diagnosis, and Treatment

IMMATURE TERATOMA: SURGICAL TREATMENT

Staging. Carcinoma confined to the corpus. Carcinoma confined to the endometrium. Less than ½ myometrial invasion. Greater than ½ myometrial invasion

بسم هللا الرحمن الرحيم. Prof soha Talaat

Janjira Petsuksiri, M.D

Transcription:

OVARIAN CARCINOMA Immune Therapy Antibodies to CA-125 (Ovarex) Vaccine therapy

OVARIAN CARCINOMA Targeted Therapy Bevacizumab (Avastin): GOG- 218 Anti-VEGF, angiogenesis inhibitor TLK 286 (Telcyta): Glutathione s-transferase binding. Reduces chemo resistance and initiates apoptosis. Trabectedin, ET743 (Yondelis) Sea Squirt Inhibits DNA repair and initiates apoptosis

Questions??

Objectives To identify the patient at risk for developing ovarian cancer Evaluation of the patient with a pelvic mass To review current surgical and post-op therapy of ovarian cancer

Ovarian Carcinoma Low Risk Premenopausal Unilateral, unilocular, cystic ovary. No family history of ovarian cancer. CA-125 <35 U/ML

Probability of BRCA1 or BRCA2 Mutation in a Woman w/breast Ca <50 Any relative with Br Ca,<50? Any relative with ovarian cancer? Proband w/bilateral Br or Ov Ca? Probability (%) + 25 + 35 + + 51 + + 71 Frank et al, J Clin Onc 16:2417-2425, 1998

Ovarian Ca Age 85 MI Ca?Stomach Throat Ca Throat Ca Breast Ca Age 42 Bilat. Breast & Ovarian Ca MI Throat Ca SAB 1950 1951 Ovarian Ca 1954 Ovarian Ca 1961 Breast Ca 1964 D.H. 49 yo G0P0

Hemorrhagic corpus luteum

Multiseptated cyst

Ovarian cancer

Ovarian Carcinoma Intermediate Risk Who Knows??

Ovarian Cancer Treatment Options Staging is surgical TAH/BSO, Tumor reduction Post-operative chemotherapy Pre-operative chemotherapy in selected cases Conservative surgery for germ cell tumors

Ovarian Cancer / Pelvic Mass Pre-treatment Evaluation Physical exam Cytological evaluation of pleural effusion if present Abd./Pelvic sono to characterize mass if no ascites present CT scan if ascites present

OVARIAN CANCER HISTOLOGY OVARY EPITHELIAL GERM CELLS STROMA

OVARIAN CANCER HISTOLOGY (W.H.O.) SEROUS MUCINOUS ENDOMETRIOD CLEAR CELL TRANSITIONAL CELL MIXED EPITHELIAL UNDIFFERENTIATED UNCLASSIFIED

OVARIAN CARCINOMA SCREENING TVS SONOGRAPHY 3220 ASYMPTOMATIC, POST- MENOPAUSAL WOMEN 44/3220 (1.4%) OVARIAN MASSES 44 EXPLORATORY LAPAROTOMY 3/44 CARCINOMA STAGE IA GRANULOSA CELL STAGE IA Gr III ADENO CA. STAGE IIIB Gr III ADENO CA. DePRIEST et al, GYN ONC, 1993

OVARIAN CANCER SCREENING 597 WOMEN SCREENED IN 12 MONTHS 449 PREMENOPAUSAL 148 POSTMENOPAUSAL ELIGIBILITY AGE > 35 YEARS FIRST DEGREE RELATIVE WITH BREAST CANCER COLON CANCER OVARIAN CANCER, OR OTHER GYN MALIG. SECOND DEGREE RELATIVE WITH OVARIAN CA KARLAN et al, Am J Obstet Gynecol, 1993 #1

OVARIAN CANCER SCREENING ASYMPTOMATIC WOMEN, (+) FAMILY HX METHOD OF SCREENING TVS FOR MORPHOLOGY PULSATILE INDEX RESISTANCE INDEX TUMOR MARKERS CA-125 LIPID-ASSOCIATED SIALIC ACID DM/7OK HER-2neu URINARY GONADOPROTEIN (UGP) GENETIC HISTORY & COUNSELLING IDENTIFIED 1 PT STAGE IA OVARIAN LMP TUMOR 1 PT STAGE IB Gr II ENDOMETRIAL CA 1/597 KARLAN et al, Am J Obstet Gynecol, 1993 #2

Ovarian Cancer / Pelvic Mass Pre-treatment Evaluation CBC, Comprehensive metabolic panel CA-125 CXR / EKG Nutritional and pulmonary evaluation Pre-op bowel preparation Surgical staging

Can any imaging technique discern malignancy?

Solid & cystic mass in an elderly patient with ascites & pleural effusion- Is it malignant??

Sometimes the diagnosis is obvious

First operation for ovarian cancer apparent stage I disease Obligatory search for occult pelvic metastasis

First Operation for ovarian cancer Obligatory search for occult abdominal metastasis Apparent stage I disease

Ovarian cancer is primarily a peritoneal disease Technique of peritoneal biopsy

Surgical technique for Ovarian Cancer Access to aortic nodes

Surgical technique for ovarian cancer Access to aortic nodes

Surgical technique for ovarian cancer Access to aortic nodes

Surgical technique for ovarian cancer Diaphragmatic biopsy

Ovarian cancer surgery technical features Exploit peritoneal surface spread pattern

Ovarian cancer surgery technical features Peritoneum over the paravesicle space is mobile

Ovarian cancer surgery technical features Reflect the ureter off the peritoneum laterally

Ovarian cancer surgery Retroperitoneal approach Posterior Cul-de-sac tumor Cervix Anterior Cul-de-sac Peritoneal tumor

Ovarian cancer surgery technical features Psoas Psoas tendon Ureter Sciatic roots Ext art Ext vein Hypogas Obt nrv

Ovarian cancer surgery extended resection Terminal ileum Transmural metastasis

Ovarian cancer surgery extended resection spleen omentum lienocolic ligament